With a robust background in healthcare and technology investments, the fund manager has successfully executed over 30 deals, emphasizing a data-driven approach. Their strategic focus includes early-stage investments primarily in Europe and North America, where they have achieved notable exits that highlight their operator-first style. The ability to identify and capitalize on emerging trends within the biotech and software sectors has been a hallmark of their investment strategy. This experience positions them as a formidable player in the venture capital landscape.